|
EIF4A2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.77060041575794E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.27559999999016E-05 |
| Normal-vs-Stage2 |
3.023700E-03 |
| Normal-vs-Stage3 |
7.44729833357383E-11 |
| Normal-vs-Stage4 |
3.36040000048499E-07 |
| Stage1-vs-Stage2 |
5.650400E-01 |
| Stage1-vs-Stage3 |
3.097600E-03 |
| Stage1-vs-Stage4 |
2.220200E-02 |
| Stage2-vs-Stage3 |
1.296780E-01 |
| Stage2-vs-Stage4 |
2.482000E-01 |
| Stage3-vs-Stage4 |
8.506200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.30430177348285E-11 |
| Normal-vs-AfricanAmerican |
1.904490E-02 |
| Normal-vs-Asian |
4.259400E-01 |
| Caucasian-vs-AfricanAmerican |
3.015400E-01 |
| Caucasian-vs-Asian |
2.914000E-01 |
| AfricanAmerican-vs-Asian |
5.849200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.81270023833247E-10 |
| Normal-vs-Female |
1.29930000003498E-06 |
| Male-vs-Female |
4.007400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.680000E-02 |
| Normal-vs-Age(41-60Yrs) |
2.3139000000505E-06 |
| Normal-vs-Age(61-80Yrs) |
4.75929962107102E-10 |
| Normal-vs-Age(81-100Yrs) |
1.003560E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.978600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.047600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.875620E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.505380E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.150350E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.819800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.201800E-01 |
| Normal-vs-Grade 2 |
1.095770E-03 |
| Normal-vs-Grade 3 |
1.66511249233281E-12 |
| Normal-vs-Grade 4 |
2.64660000026673E-07 |
| Grade 1-vs-Grade 2 |
1.769230E-01 |
| Grade 1-vs-Grade 3 |
1.678020E-03 |
| Grade 1-vs-Grade 4 |
1.230220E-02 |
| Grade 2-vs-Grade 3 |
4.89969999994955E-06 |
| Grade 2-vs-Grade 4 |
6.993700E-04 |
| Grade 3-vs-Grade 4 |
6.286200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.557800E-03 |
| Normal-vs-ccB subtype |
2.19079976382375E-10 |
| ccA subtype-vs-ccB subtype |
4.356600E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.10609999626999E-08 |
| Normal-vs-N1 |
2.11370032587865E-10 |
| N0-vs-N1 |
9.991200E-04 |
|
|
